tiprankstipranks
pc:lig4j

Lighthouse Pharmaceuticals

Lighthouse Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel small-molecule therapies for neurodegenerative and inflammatory diseases. The company is advancing its lead program, LHP588, through a Phase 2 SPRING trial targeting P. gingivalis-positive mild to moderate Alzheimer's disease while continuing to expand its therapeutic pipeline.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$12M
Total Amount Raised$12M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$12M
Latest Funding Amount$12M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Apr 28, 2026
Series A
$12.00M

Investors

Investor Name
Funding Round

Related News and Analysis